How ACTEMRA Is Given
How your child will receive ACTEMRA
If you and your child’s doctor are deciding on treating with ACTEMRA or your child is just starting ACTEMRA, it’s important to know how ACTEMRA is given.
Some medications are given orally as a pill or liquid, but others are given by an injection or as an intravenous (IV) infusion. ACTEMRA is a biologic that is administered as an IV infusion for PJIA.
It’s also important to know that ACTEMRA is also available as a subcutaneous (SC) injection, which is given under the skin. ACTEMRA for SC injection is not intended for intravenous use. And ACTEMRA SC injections are only available for RA patients, and should not be used to treat patients with PJIA.
ACTEMRA is given once every 4 weeks by IV infusion.
The facts about infusions:
- An infusion is a way to deliver medicine into the body
- During an infusion, a needle distributes liquid medicine directly into a vein
- Infusions are used to treat a variety of conditions
- Infusions usually take place in a doctor's office or an infusion center
- A trained healthcare professional is there to help you and your child manage the infusion and watch for any reactions. Click here to see the most important things you should know about ACTEMRA
Children’s ACTEMRA doses are based on weight. So before every infusion appointment, your child will be weighed. If your child’s weight changes, you and your child’s doctor may decide if a change of dose is necessary.
Important Side Effect Information | Serious infections
Before starting ACTEMRA, tell your child’s healthcare provider if your child thinks he or she has an infection or has symptoms of an infection, with or without fever, such as sweating or chills, shortness of breath, warm, red or painful skin or sores on his or her body, feels very tired, muscle aches, blood in phlegm, diarrhea or stomach pain, cough, weight loss, burning when he or she urinates or urinating more often than normal; is being treated for an infection; gets a lot of infections or has infections that keep coming back; has diabetes, HIV, or a weak immune system; has TB or has been in close contact with someone with TB; lived in or currently lives in parts of the United States, such as the Ohio or Mississippi River Valleys and the Southwest, where there is an increased chance of getting certain kinds of fungal infections; or has or has had hepatitis B.
After starting ACTEMRA, call your child's healthcare provider right away if your child has any symptoms of an infection.
Patients should not take ACTEMRA if they are allergic to any of its ingredients.
Look out for side effects at every infusion
Remember to keep an eye out for any side effects during or after your child’s infusion.
These reactions could include shortness of breath or trouble breathing; swelling of the lips, tongue, or face; chest pain; feeling dizzy or faint; or moderate or severe abdominal pain or vomiting.
Seek medical attention right away and contact a doctor if your child experiences any treatment reactions.
Before reading more, please see the Important Side Effect Information for ACTEMRA
This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.
Important Side Effect Information
After reading about ACTEMRA, please talk to your healthcare provider if you have any questions.
- Available by medical prescription only
- For adults with moderately to severely active rheumatoid arthritis (RA) who have used one or more disease modifying antirheumatic drugs (DMARDs), such as methotrexate, that did not provide enough relief
- For adults with giant cell arteritis (GCA)
- For people with active PJIA ages 2 and above
- For people with active SJIA ages 2 and above
ACTEMRA is not approved for subcutaneous use in people with PJIA or SJIA.
It is not known if ACTEMRA is safe and effective in children with PJIA or SJIA under 2 years of age or in children with conditions other than PJIA or SJIA.
ACTEMRA can cause serious side effects
ACTEMRA changes the way your immune system works. This can make you more likely to get infections or make any current infection worse. Some people have died from these infections.
Before taking ACTEMRA, tell your healthcare provider if you have:
- An infection, think you may have an infection, are being treated for an infection, or get a lot of infections that return. Infection signs, with or without a fever, include:
- Sweating or chills
- Shortness of breath
- Warm, red or painful skin or sores on your body
- Feel very tired
- Muscle aches
- Blood in phlegm
- Diarrhea or stomach pain
- Weight loss
- Burning when you urinate or urinating more often than normal
- Any of the following conditions that may give you a higher chance of getting infections. These include: diabetes, HIV, or a weak immune system
- Tuberculosis (TB) or have been in close contact with someone who has TB. Your healthcare provider should test you for TB before starting ACTEMRA and during treatment with ACTEMRA
- Lived in or currently live in parts of the United States known for fungal infections. These parts include the Ohio and Mississippi River Valleys and the Southwest
- Hepatitis B or have had hepatitis B
Be sure to contact your healthcare provider or nurse if you see any signs of these side effects.
If you have diverticulitis (inflammation in parts of the large intestine), talk to your healthcare provider before taking ACTEMRA.
Some people taking ACTEMRA may develop a hole in the wall of their stomach or intestines (also known as a perforation). This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or methotrexate.
Tell your healthcare provider right away if you see any of these side effects:
- Stomach-area pain that does not go away
- Change in your bowel habits
Changes in blood test results
Your healthcare provider should do blood tests before you start receiving ACTEMRA. If you have rheumatoid arthritis (RA) or giant cell arteritis (GCA) your healthcare provider should do blood tests 4 to 8 weeks after you start receiving ACTEMRA and then every 3 months after that. If you have polyarticular juvenile idiopathic arthritis (PJIA) you will have blood tests done every 4 to 8 weeks during treatment. If you have systemic juvenile idiopathic arthritis (SJIA) you will have blood tests done every 2 to 4 weeks during treatment. These blood tests are to check for the following side effects of ACTEMRA:
Low neutrophil count: neutrophils are white blood cells that help the body fight infection
Low platelet count: platelets are blood cells that help with clotting, which stops bleeding
Increase in liver function test levels
Increase in blood cholesterol levels
You should not receive ACTEMRA if your neutrophil and platelet counts are too low or your liver function test levels are too high. These may cause your healthcare provider to stop your ACTEMRA treatment for a time or change your dose. Your cholesterol levels should be checked 4 to 8 weeks after the start of your treatment, and then every 6 months after that.
Increased risk of cancer
ACTEMRA may increase your risk of certain cancers by changing the way your immune system works.
Hepatitis B infection
If you have hepatitis B, a virus that affects the liver, or are a carrier of the virus, ACTEMRA can cause the virus to become active. Your healthcare provider should test you for hepatitis B before starting treatment. Tell your healthcare provider right away if you see any signs of these symptoms:
- Feeling very tired
- Dark urine
- Skin or eyes look yellow
- Clay-colored bowel movements
- Stomach discomfort
- Skin rash
- Little or no appetite
- Muscle aches
Serious allergic reactions
Serious allergic reactions, including death, can happen with ACTEMRA infusions or injections, even if they did not occur with an earlier infusion or injection. If you had hives, a rash, or experienced flushing after injecting, you should tell your healthcare provider or nurse before your next injection.
Contact 911 immediately, as well as your healthcare provider or nurse, if you experience any of these reactions:
- Shortness of breath or trouble breathing
- Swelling of lips, tongue, or face
- Chest pain
- Feeling dizzy or faint
- Moderate or severe abdominal pain or vomiting
Nervous system problems
While rare, multiple sclerosis has been diagnosed in some people taking ACTEMRA.
Most common side effects
Tell your healthcare provider if you have these or any other side effect that bothers you or does not go away:
Upper respiratory tract infections (like common cold and sinus infections)
Increased blood pressure (also called hypertension)
Injection site reactions
ACTEMRA & pregnancy
Tell your healthcare provider if you are planning to become pregnant, are pregnant, plan to breast-feed, or are breast-feeding. You and your healthcare provider should decide if you will take ACTEMRA or breast-feed. You should not do both. If you are pregnant and taking ACTEMRA, join the pregnancy registry. The purpose of this registry is to check the health of the pregnant mother and her baby. To learn more, call 1-877-311-8972 or talk to your healthcare provider to register.
Reporting side effects
Tell your healthcare provider right away if you are experiencing any side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch. You may also call Genentech at 1-888-835-2555.